| 4886 |
Centers for Disease Control and Prevention |
Html |
en |
Transmission Workshop 2010 |
null |
| CDC | 0.314967 |
| modes | 0.305676 |
| droplet | 0.267967 |
| Funding Opportunity Announcement | 0.549181 |
| questions | 0.232627 |
| influenza transmission | 0.958692 |
| Atlanta | 0.236594 |
| Persons | 0.230494 |
| contact | 0.26006 |
| airborne transmission | 0.555843 |
| FOA | 0.273101 |
| links | 0.231658 |
| state | 0.233579 |
|
| Virologic Evaluation | 0.38242 |
| gaps | 0.252409 |
| art science | 0.401997 |
| Dr. Eileen Yee | 0.562617 |
| Influenza Virus Transmission | 0.783206 |
| Meeting materials | 0.384967 |
| cdc.gov | 0.257651 |
| additional workshop materials | 0.522509 |
| relative contributions | 0.414155 |
| purposes | 0.239081 |
| information | 0.230538 |
| Georgia | 0.236536 |
| best approaches | 0.404577 |
|
CLICK HERE |
| 5647 |
Centers for Disease Control and Prevention |
Html |
en |
p-Nitroaniline - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6438 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables - December 9, 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| provisional 4-week totals | 0.768429 |
| Mortality Tables | 0.473532 |
| equine encephalitis virus | 0.613099 |
| Mortality Weekly Report | 0.472291 |
| Viral hemorrhagic fever¶¶¶ | 0.45547 |
| provisional cases | 0.684413 |
| Hantavirus pulmonary syndrome§ | 0.460405 |
| Staphylococcus aureus§ | 0.458343 |
| New York City | 0.443145 |
| acute hepatitis | 0.496037 |
| 2011-12 influenza season | 0.4702 |
| Cum | 0.452829 |
| noncholera Vibrio species | 0.45663 |
| influenza A virus | 0.474437 |
| National Center | 0.580134 |
| CDC Home CDC | 0.480039 |
| Hemolytic uremic syndrome | 0.461888 |
| California serogroup virus | 0.498979 |
| meningococcal disease | 0.596834 |
| historical data | 0.533605 |
| Influenza Division | 0.452369 |
| Ñ?ЛП
Notifiable Diseases | 0.531795 |
| Cumulative year-to-date counts | 0.451997 |
| 2009 pandemic | 0.509537 |
|
| Respiratory Diseases | 0.446131 |
| NN | 0.584875 |
| United States | 0.939729 |
| Vancomycin-resistant Staphylococcus aureus§ | 0.453012 |
| novel influenza | 0.544073 |
| I. Provisional cases | 0.515739 |
| 5-year weekly average†| 0.481789 |
| notifiable diseases | 0.843151 |
| Vancomycin-intermediate Staphylococcus aureus§ | 0.452514 |
| Eastern equine encephalitis | 0.473238 |
| pandemic influenza | 0.516342 |
| Influenza-associated pediatric mortality§ | 0.453417 |
| viral hemorrhagic fever | 0.445776 |
| Western equine encephalitis | 0.472567 |
| Polio virus Infection | 0.461611 |
| Total case counts | 0.446714 |
| notifiable disease reports | 0.746457 |
| current 4-week total | 0.478122 |
| Vector-Borne Infectious Diseases | 0.459252 |
| Chlamydia trachomatis infection | 0.4441 |
| TABLE I. | 0.475951 |
| dengue hemorrhagic fever | 0.44919 |
| subsequent 4-week periods | 0.467208 |
| West Nile virus | 0.457984 |
|
CLICK HERE |
| 6502 |
Centers for Disease Control and Prevention |
Html |
en |
Yellow Fever Main Page |
Information on Yellow Fever. Provided by the U.S. Centers for Disease Control and Prevention. |
| South America | 0.440708 |
| Steps | 0.323779 |
| Yellow fever disease | 0.711273 |
| severe liver disease | 0.53845 |
| bleeding | 0.332779 |
| yellow fever | 0.919129 |
| infected mosquitoes | 0.466154 |
| U.S. travelers | 0.434804 |
| rare cause | 0.430273 |
| yellow fever virus | 0.875836 |
| bite | 0.333418 |
| possibility | 0.328436 |
| travel history | 0.418952 |
|
| subtropical areas | 0.463266 |
| severity | 0.337857 |
| Africa | 0.322551 |
| protective clothing | 0.421207 |
| specific treatment | 0.415515 |
| physical findings | 0.425826 |
| symptoms | 0.331882 |
| infected mosquito | 0.477476 |
| insect repellent | 0.440236 |
| exposure | 0.325238 |
| fever virus infection | 0.660533 |
| self-limited febrile illness | 0.590279 |
|
CLICK HERE |
| 9053 |
Centers for Disease Control and Prevention |
Html |
en |
Parasites - Features |
A parasite is an organism that lives on or in a host and gets its food from or at the expense of its host. Parasites can cause disease in humans. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 10430 |
Centers for Disease Control and Prevention |
Html |
en |
Vital Signs: Where's the sodium?'Announcements'DHDSP'CDC |
null |
| average | 0.230266 |
| important public health | 0.535868 |
| healthy diet | 0.366453 |
| visit http://www.cdc.gov/vitalsigns/Sodium/index.html | 0.36387 |
| foods | 0.319055 |
| edition | 0.232397 |
| different sodium levels | 0.700833 |
| milligrams | 0.22764 |
| diets | 0.2378 |
| example | 0.227183 |
| sodium Americans | 0.635078 |
| Vital Signs program | 0.542867 |
| heart disease | 0.497511 |
| chicken noodle soup | 0.507679 |
| American Heart | 0.378082 |
|
| action | 0.232913 |
| mg | 0.241727 |
| sodium increases | 0.630959 |
| types | 0.227955 |
| person’s risk | 0.368109 |
| health care dollars | 0.482275 |
| Different brands | 0.346132 |
| stroke | 0.267936 |
| labels | 0.227487 |
| sodium | 0.989783 |
| high blood pressure | 0.788203 |
| medical costs | 0.358104 |
| vascular diseases | 0.525872 |
| CDC Vital Signs | 0.88933 |
|
CLICK HERE |
| 11296 |
Centers for Disease Control and Prevention |
Html |
en |
Guidelines for Evaluation of US Patients Suspected of Having Ebola Virus Disease- HAN Archive - 00364| Health Alert Network |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| EVD-affected countries | 0.731784 |
| single patient room | 0.72835 |
| affected countries | 0.734186 |
| ebola virus | 0.907213 |
| infection control professionals | 0.762751 |
| Environmental infection control | 0.748092 |
| direct patient care | 0.748255 |
| detailed instructions | 0.727278 |
| state health departments | 0.748956 |
| specimen submission form | 0.834176 |
| World Health Organization | 0.890066 |
| CDC laboratory testing | 0.879979 |
| patients | 0.738228 |
| Suspected Ebola Hemorrhagic | 0.775557 |
| body fluids | 0.858824 |
| public health officials | 0.734815 |
| primary care physicians | 0.736408 |
| public health risks | 0.766461 |
| mucous membrane exposure | 0.762056 |
| EVD | 0.840121 |
| EVD patients | 0.723582 |
| low-risk exposure | 0.843189 |
| direct unprotected contact | 0.746016 |
| blood work findings | 0.90161 |
| intensive care physicians | 0.732142 |
|
| hospital infection control | 0.782554 |
| standard biosafety precautions | 0.725109 |
| CDC Health Alert | 0.820955 |
| direct skin contact | 0.749186 |
| Ebola virus infection | 0.765689 |
| abnormal blood work | 0.757965 |
| appropriate PPE | 0.822035 |
| fever | 0.735174 |
| infection control | 0.923874 |
| Healthcare provider protection | 0.73384 |
| travel to—an area | 0.730262 |
| local health department | 0.746907 |
| compatible clinical symptoms | 0.743367 |
| Diligent environmental cleaning | 0.72483 |
| state health department | 0.751591 |
| Ebola Virus Disease | 0.774139 |
| local health departments | 0.861792 |
| Epidemiologic risk factors | 0.726282 |
| high-risk exposure | 0.821293 |
| West Africa | 0.744912 |
| healthcare workers | 0.737461 |
| infectious disease specialists | 0.736727 |
| u.s. hospitals | 0.777835 |
| infection control procedures | 0.860564 |
|
CLICK HERE |
| 11382 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Warns of Sillicosis Risks in Construction, Suggests Measures to Reduce Exposure (96-120) |
null |
| construction workers | 0.496201 |
| lung tissue | 0.347156 |
| worksite contaminants | 0.353314 |
| Preventing Silicosis | 0.425856 |
| masonry products | 0.3491 |
| NIOSH requests | 0.373227 |
| abrasive blasting | 0.395579 |
| construction activities | 0.394998 |
| good working order | 0.380797 |
| washable protective clothes | 0.378611 |
| respirable crystalline silica | 0.960553 |
| NIOSH | 0.399786 |
| small amounts | 0.34882 |
| lower risks | 0.352395 |
| practical steps | 0.351502 |
| equipment manufacturers | 0.346225 |
| crystalline silica dust | 0.642008 |
| dust control systems | 0.391584 |
| workplace exposure | 0.361862 |
| health effects | 0.345203 |
| adequate respiratory protection | 0.382725 |
| good personal hygiene | 0.378888 |
| work areas | 0.384537 |
| Director Linda Rosenstock | 0.390138 |
| economic costs | 0.346813 |
|
| NIOSH Alert | 0.382578 |
| silica exposures | 0.45368 |
| high dust concentrations | 0.400484 |
| silica sand | 0.500838 |
| State health departments | 0.379494 |
| Occupational Safety | 0.351387 |
| hazardous materials | 0.345621 |
| adjacent workers | 0.354959 |
| breathing respirable crystalline | 0.485712 |
| National Institute | 0.353709 |
| health community work | 0.389566 |
| abrasive blasting materials | 0.38434 |
| silica exposure | 0.526193 |
| NIOSH REL | 0.369285 |
| unnecessary exposure | 0.359921 |
| fatal respiratory disease | 0.4768 |
| construction industry | 0.353488 |
| sweeping concrete | 0.349065 |
| Post warning signs | 0.380771 |
| silicosis | 0.500921 |
| Conduct air monitoring | 0.377939 |
| work practices | 0.345179 |
| periodic medical examinations | 0.380371 |
| worker exposures | 0.352414 |
|
CLICK HERE |
| 14098 |
Centers for Disease Control and Prevention |
Html |
en |
Zika Virus Spreads to New Areas - Region of the Americas, May 2015-January 2016 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| health care provider | 0.437435 |
| Virus-specific cross-neutralization testing | 0.433289 |
| human disease cases | 0.442744 |
| Zika virus | 0.923295 |
| best way | 0.435411 |
| limited areas | 0.437053 |
| pregnant women | 0.478621 |
| virus disease cases§ | 0.486047 |
| Health care providers | 0.499264 |
| mosquito-borne flavivirus | 0.440905 |
| mosquito-to-human transmission | 0.433306 |
| World Health Organization | 0.441813 |
| ongoing Zika virus | 0.531683 |
| Zika virus disease | 0.651369 |
| compatible travel history | 0.433998 |
| possible congenital infection | 0.444737 |
| nonpurulent conjunctivitis | 0.434613 |
| public health practice | 0.442585 |
| Aedes aegypti mosquitoes | 0.450065 |
| primary flavivirus infections | 0.435973 |
| Zika virus transmission | 0.659433 |
| maculopapular rash | 0.454455 |
| American Health Organization | 0.474493 |
| secondary flavivirus infection | 0.446763 |
| Ae. albopictus mosquitoes | 0.438162 |
|
| United States | 0.528212 |
| Aedes species mosquitoes | 0.437861 |
| intrauterine transmission | 0.433229 |
| Zika virus infection | 0.770249 |
| Pan American Health | 0.473877 |
| continental United States | 0.518373 |
| State health departments | 0.43678 |
| local health department | 0.470968 |
| local transmission | 0.54402 |
| state health department | 0.44164 |
| acute onset | 0.454072 |
| symptomatic disease | 0.440796 |
| local health departments | 0.439326 |
| Zika virus infections | 0.554255 |
| intrapartum transmission | 0.433273 |
| virus disease cases | 0.500745 |
| congenital infection | 0.464543 |
| sexual transmission | 0.433253 |
| chikungunya virus infection | 0.509006 |
| Aedes albopictus mosquitoes | 0.443691 |
| laboratory diagnostic testing | 0.433509 |
| Febrile pregnant women | 0.437425 |
| Zika virus testing | 0.50752 |
| local human-to-mosquito-to-human spread | 0.437648 |
|
CLICK HERE |
| 16327 |
Centers for Disease Control and Prevention |
Html |
en |
FastStats - Prostate Disease |
null |
| Discharged Hospice Care | 0.939501 |
| Home Health Care | 0.798078 |
| PDF | 0.216665 |
| United States | 0.477849 |
| MB | 0.208697 |
| Final Data | 0.468852 |
|
| KB | 0.408223 |
| procedure category | 0.604145 |
| Deaths | 0.214197 |
| National Hospital Discharge | 0.988417 |
| selected patient characteristics | 0.903059 |
|
CLICK HERE |